Literature DB >> 14982808

Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers.

I M Rigter1, H G Schipper, R P Koopmans, H J M van Kan, H W Frijlink, P A Kager, H-J Guchelaar.   

Abstract

This study of healthy volunteers shows that the relative bioavailability of albendazole formulations that use arachis oil-polysorbate 80 or hydroxypropyl-beta-cyclodextrin as an excipient was enhanced 4.3- and 9.7-fold compared to the results seen with commercial tablets. Administration of macrogol suppositories did not result in measurable plasma concentrations of albendazole sulfoxide.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14982808      PMCID： PMC353162          DOI： 10.1128/AAC.48.3.1051-1054.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Effect of surfactants on albendazole absorption.

Authors:  J L del Estal; A I Alvarez; C Villaverde; P Coronel; S Fabra; J G Prieto
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

2.  Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.

Authors:  B Evrard; P Chiap; P DeTullio; F Ghalmi; G Piel; T Van Hees; J Crommen; B Losson; L Delattre
Journal:  J Control Release       Date:  2002-12-13       Impact factor: 9.776

3.  Increased systemic availability of albendazole when taken with a fatty meal.

Authors:  H Lange; R Eggers; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique.

Authors:  N Kohri; Y Yamayoshi; H Xin; K Iseki; N Sato; S Todo; K Miyazaki
Journal:  J Pharm Pharmacol       Date:  1999-02       Impact factor: 3.765

5.  Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

Authors:  M Homeida; W Leahy; S Copeland; M M Ali; D W Harron
Journal:  Ann Trop Med Parasitol       Date:  1994-10

6.  Effect of dose increase or cimetidine co-administration on albendazole bioavailability.

Authors:  H G Schipper; R P Koopmans; J Nagy; J J Butter; P A Kager; C J Van Boxtel
Journal:  Am J Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.345

7.  Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability.

Authors:  J Nagy; H G Schipper; R P Koopmans; J J Butter; C J Van Boxtel; P A Kager
Journal:  Am J Trop Med Hyg       Date:  2002-03       Impact factor: 2.345

8.  The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics.

Authors:  K Awadzi; M Hero; N O Opoku; D W Büttner; P A Coventry; M A Prime; M L Orme; G Edwards
Journal:  Trop Med Parasitol       Date:  1994-09

9.  HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies.

Authors:  Dennis Kitzman; Kuei-Ju Cheng; Lawrence Fleckenstein
Journal:  J Pharm Biomed Anal       Date:  2002-10-15       Impact factor: 3.935

10.  Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.

Authors:  Wang Mingjie; Xiao Shuhua; Chai Junjie; Liang Bin; Fu Cheng; Shen Weixia; Peter Hotez
Journal:  Acta Trop       Date:  2002-08       Impact factor: 3.112
View more
  10 in total

1.  Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.

Authors:  Cong-shan Liu; Hao-bing Zhang; Bin Jiang; Jun-min Yao; Yi Tao; Jian Xue; Ai-dan Wen
Journal:  Parasitol Res       Date:  2012-06-04       Impact factor: 2.289

2.  Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.

Authors:  Janki Fadke; Jagruti Desai; Hetal Thakkar
Journal:  AAPS PharmSciTech       Date:  2015-05-20       Impact factor: 3.246

3.  Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans.

Authors:  Yogesh Sutar; Sophie R Fulton; Sagarkumar Paul; Sophie Altamirano; Susmit Mhatre; Hiwa Saeed; Pratikkumar Patel; Sudipta Mallick; Roopal Bhat; Vandana B Patravale; Harsh Chauhan; Kirsten Nielsen; Abhijit A Date
Journal:  ACS Infect Dis       Date:  2021-09-01       Impact factor: 5.084

4.  Human echinococcosis: a neglected disease.

Authors:  António Menezes da Silva
Journal:  Gastroenterol Res Pract       Date:  2010-08-31       Impact factor: 2.260

5.  Ten-year follow-up of children with hydatid cysts.

Authors:  Tuğba Şişmanlar Eyüboğlu; Tuğba Ramaslı Gürsoy; Ayşe Tana Aslan; Sevgi Pekcan; Işıl İrem Budakoğlu
Journal:  Turk Pediatri Ars       Date:  2019-09-25

6.  Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations.

Authors:  Laura Ceballos; Charles Mackenzie; Timothy Geary; Luis Alvarez; Carlos Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

7.  Albendazolesulphoxide concentrations in plasma and hydatid cyst and prediction of parasitological and clinical outcomes in patients with liver hydatidosis caused by Echinococcus granulosus.

Authors:  Tomislava Skuhala; Vladimir Trkulja; Mislav Runje; Dalibor Vukelic; Bosko Desnica
Journal:  Croat Med J       Date:  2014-04       Impact factor: 1.351

8.  Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule.

Authors:  L Ceballos; L Alvarez; C Mackenzie; T Geary; C Lanusse
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-09-25       Impact factor: 4.077

9.  Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.

Authors:  Joseph D Turner; Raman Sharma; Ghaith Al Jayoussi; Hayley E Tyrer; Joanne Gamble; Laura Hayward; Richard S Priestley; Emma A Murphy; Jill Davies; David Waterhouse; Darren A N Cook; Rachel H Clare; Andrew Cassidy; Andrew Steven; Kelly L Johnston; John McCall; Louise Ford; Janet Hemingway; Stephen A Ward; Mark J Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

10.  High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects.

Authors:  Dolores Ochoa; Miriam Saiz-Rodríguez; Esperanza González-Rojano; Manuel Román; Sergio Sánchez-Rojas; Aneta Wojnicz; Ana Ruiz-Nuño; Alfredo García-Arieta; Francisco Abad-Santos
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.